Blood pressure (BP) monitoring devices are used for the measurement three types of blood pressure: high, low, and blood pressure, which shows excessive or maladaptive fluctuations. Blood pressure is one of the main risk factors for chronic heart disease diseases and strokes, which are the leading cause of death around the world.
The global blood pressure monitoring devices market was valued at $1,981 million in 2015, and is estimated to reach $2,926 million by 2022, registering a CAGR of 5.7% from 2016 to 2022. This is due to the increase in importance of blood pressure monitoring devices in home care settings and emergence of advanced technologies. In addition, upsurge in geriatric population and sedentary lifestyle have fueled the demand for blood pressure monitoring devices. Moreover, the increase in obese population and improvement in awareness about the harmful effects of hypertension have fueled the market growth. However, lack of awareness about these devices in the low- and middle-income countries is use to hamper the market growth.
The blood pressure monitoring devices market is segmented on the basis of product type, and geography. Based on product type, the market is classified into aneroid BP monitors, digital BP monitors, blood pressure instrument accessories, and ambulatory BP monitors. Furthermore, on the basis of four geographical regions, it is categorized as North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, Malaysia, and rest of Asia-Pacific), and LAMEA (Brazil, Middle East, Africa, and rest of LAMEA).
Prominent players have adopted product development including product launches and approvals, as their key developmental strategy to expand their product portfolio. For instance, Omron healthcare was the first company to manufacture a wearable device called Project Zero Wrist Blood Pressure Monitor in April 2016. It was the first watch-sized sphygmomanometer that accurately measured blood pressure of the wearer. Moreover, reimbursement policies for blood pressure monitoring devices have fueled the demand for these products. For instance, Medicare offers reimbursement for ambulatory blood pressure monitoring (ABPM) devices used for a patient receiving blood dialysis at home or suffering from white coat hypertension. The three codes covered by Medicare for ABPM devices are 93784, 93786, and 93790.
KEY BENEFITS
This report provides an extensive analysis of the current and emerging market trends, estimations and dynamics from 2014 to 2022 in the global blood pressure monitoring devices market to identify prevailing opportunities.
Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities.
This study evaluates the competitive landscape of the market to predict the competitive environment across geographies.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- and country-wise blood pressure monitoring devices market conditions are comprehensively analyzed.
Blood Pressure Monitoring Devices Market Key Segments:
By Product Type
Aneroid BP Monitors
Digital BP Monitors
Blood Pressure Instrument Accessories
Ambulatory BP Monitors
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Indonesia
Thailand
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Venezuela
Saudi Arabia
Republic of South Africa
Colombia
Argentina
Rest of LAMEA
KEY PLAYERS
A&D Company, Limited
Contec Medical Systems Co., Ltd.
General Electric Company
Halma plc
Hill-Rom Holdings, Inc.
Koninklijke Philips N.V.
Masimo Corporation
Nihon Kohden Corporation
Omron Corporation
Smith's Group Plc
